UNC and pharmaceuticals giant GlaxoSmithKline are joining forces to try developing a cure for HIV/AIDS, with the British company pledging a five-year, $20 million contribution to the effort.
GSK is also chipping in a 10-person research team, to work with faculty members, post-doctoral fellows and graduate students attached to four different labs in UNC’s medical and pharmacy schools.
{iframe}http://www.heraldsun.com/news/showcase/x1222491041/UNC-GSK-joining-forces-on-HIV-research{/iframe}